The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.20
Bid: 82.40
Ask: 83.40
Change: -0.80 (-0.95%)
Spread: 1.00 (1.214%)
Open: 82.60
High: 84.20
Low: 82.60
Prev. Close: 84.00
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on P&H contract and current trading

13 Dec 2021 07:00

RNS Number : 3574V
Costain Group PLC
13 December 2021
 

 

Costain Group PLC

13 December 2021

 

 

Update on Peterborough & Huntingdon contract and current trading

 

Costain is providing an update on the adjudication process regarding the legacy Peterborough and Huntingdon contract dispute. In addition, we are providing an update to guidance and re-confirm that full year adjusted operating profit is expected to be in line with market expectations. Year end net cash, before any period end timing benefits, will now be ahead of market expectations at around £100m.

 

We have now received several adjudication decisions, the most recent and material of which was received on 10 December 2021. In this claim, the adjudicator found in our favour on principle in respect of three out of the four compensation events.

 

However, he has chosen not to determine the financial amounts in respect of these compensation events. We will pursue a financial settlement with National Grid in respect of these compensation events. As not all compensation events have been decided in our favour, we now expect there to be an overall cash outflow in respect of the contract.

 

Under the terms of the termination agreement with National Grid, there is an expected requirement to make a payment of £53.5m in January 2022, which now represents the maximum cash outflow under the contract. Given the recent adjudication decision, we have an entitlement to recover a proportion of this payment and will be discussing the timing and amount with National Grid. The payment, if made, will not affect our banking arrangements and we will continue to have a strong balance sheet that enables us to deliver our business plan. There will be an associated charge to the income statement for the current financial year reflecting such payment.

 

We are making good progress on our journey to transform the business, reduce risk and improve returns. This, combined with the considerable government investment in infrastructure, allows us to look forward with confidence.

 

Our next scheduled update will be the 2021 full year results, which are due to be announced on 9 March 2022.

 

 

Enquiries

 

Investors and analysts

Louise Bryant, Costain

 

 

+44 7813 210 809

Financial media

Tim Rowntree, MHP

Peter Hewer, MHP

 

+44 203 128 8771

Costain@mhpc.com

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The person responsible for this announcement on behalf of Costain is Louise Bryant, Group Director of Communications & Investor Relations.

 

Background to the Peterborough & Huntingdon contract

On 29 June 2020, we announced that a termination and settlement agreement had been reached with National Grid to cease work on the Peterborough & Huntingdon gas compressor project following a significant change in scope. The agreement included a legal process, through adjudications, to agree up to £80.0m of identified compensation events, recover costs to date and eliminate a potential liability to National Grid for completing the works.

 

To date, we have recorded a charge to the income statement of £49.3m reflecting the cash position at termination. As outlined at our interim results in August, under the terms of the agreement, the cumulative outcome for us of these adjudications ranged from an additional cash receipt of up to a maximum of £50.0m to a cash payment of up to a maximum of £57.3m.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEANAAFLEFFFA
Date   Source Headline
25th Apr 202411:41 amRNSScrip Dividend Reference Price
9th Apr 20244:16 pmRNSDirector/PDMR Shareholding
9th Apr 20241:32 pmRNSDirector/PDMR Shareholding
9th Apr 20249:33 amRNSAnnual Report and Accounts and Notice of 2024 AGM
4th Apr 20249:55 amRNSAdditional Listing
15th Mar 20248:30 amRNSKey Partner for Landmark Carbon Capture Project
12th Mar 20247:01 amRNSDirectorate Change
12th Mar 20247:00 amRNS2023 Full Year Results
27th Feb 202412:06 pmRNSInvestor Presentation via Investor Meet Company
10th Jan 20247:00 amRNSAMP8 Water Framework Win with NWG & Trading Update
2nd Jan 202412:56 pmRNSBlock listing Interim Review
1st Nov 202312:15 pmRNSTotal Voting Rights
27th Oct 20231:00 pmRNSDirector/PDMR Shareholding
25th Oct 20231:00 pmRNSAdditional Listing
19th Oct 20231:00 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirectorate Change
28th Sep 202312:00 pmRNSScrip Dividend Reference Price
25th Sep 20237:00 amRNSCostain and Ofwat Water Seminar
8th Sep 20232:26 pmRNSBlock listing Interim Review
5th Sep 20237:00 amRNSDividend Declaration
23rd Aug 20237:00 amRNSResults for the six months ended 30 June 2023
16th Aug 202310:00 amRNSInterim Results Investor Q&A
26th Jul 20237:00 amRNSCostain Refinancing of Bank and Bonding Facilities
17th Jul 20237:00 amRNSCostain Announces Key Contract Extension
30th Jun 20237:00 amRNSNew Payment Plan with Pension Scheme Trustee
22nd Jun 202310:38 amRNSCostain Appointed Magnox Decommissioning Framework
8th Jun 20234:17 pmRNSUpdate Regarding A66 Project
11th May 20234:49 pmRNSResult of AGM
11th May 20237:00 amRNSAGM Statement
20th Apr 20239:40 amRNSExternal Appointment
6th Apr 20232:29 pmRNSGrant of Share Plan Awards
6th Apr 202311:51 amRNSHolding(s) in Company
4th Apr 202310:33 amRNSNotice of AGM and Annual Report and Accounts
30th Mar 202312:58 pmRNSLong Term Incentive Plan - Listing Application
14th Mar 20237:00 amRNSResults For The Year Ended 31 December 2022
30th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20231:09 pmRNSBlock Listing Six Monthly Return
21st Dec 202212:47 pmRNSDirector/PDMR Shareholding
29th Nov 20227:00 amRNSCostain Partners with Heathrow Airport
21st Nov 20227:00 amRNSExtension of Bank Debt and Bonding Facilities
1st Nov 20224:42 pmRNSDirector/PDMR Shareholding
30th Sep 20222:32 pmRNSA303 Delivery Assurance Partnership
27th Sep 20227:00 amRNSDirectorate Change
24th Aug 20227:00 amRNSStrong operational resilience and cash performance
20th Jul 20227:00 amRNSTrading in line with strong cash performance
1st Jul 20224:40 pmRNSSecond Price Monitoring Extn
1st Jul 20224:35 pmRNSPrice Monitoring Extension
1st Jul 20229:00 amRNSBlock listing Interim Review
16th Jun 20222:17 pmRNSTR-1: Notification of Major holdings
1st Jun 202211:10 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.